Telogen Effluvium: Review Article

    December 2024 in “ Medical alphabet
    E. M. Gesheva, A. R. Ereshko
    Image of study
    TLDR Understanding and addressing the causes of telogen effluvium is crucial for effective treatment.
    The review article on telogen effluvium (TE) provides an updated classification and detailed clinical features of diffuse TE, exploring its various causes and triggers. It highlights the importance of accurate diagnosis and discusses treatment options for different forms of TE. The article emphasizes the need for understanding the underlying factors contributing to TE to effectively manage and treat this condition.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results

    Related Community Posts Join

    6 / 609 results

    Similar Research

    6 / 1000+ results
      Telogen Effluvium: A Common Form of Hair Loss

      research Telogen Effluvium: A Common Form of Hair Loss

      July 2018 in “Elsevier eBooks”
      Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.
      Telogen Effluvium: A Review of Acute and Chronic Forms

      research Telogen Effluvium: A Review of Acute and Chronic Forms

      67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
      Practical Aspects of Telogen Effluvium

      research Practical Aspects of Telogen Effluvium

      April 2024 in “Dermatovenerologiâ, kosmetologiâ”
      Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.